Literature DB >> 33601305

Prevalence and variability in use of physical and chemical restraints in residential aged care facilities: A systematic review and meta-analysis.

Den-Ching A Lee1, Lauren M Robins2, J Simon Bell3, Velandai Srikanth4, Ralph Möhler5, Keith D Hill6, Debra Griffiths7, Terry P Haines2.   

Abstract

BACKGROUND: Use of physical and chemical restraints are common in residential aged care facilities worldwide. Restraint use can pose harm to residents even causing deaths.
OBJECTIVE: To synthesize the prevalence and variability in physical and chemical restraint use, and examine factors that may contribute to this variability of prevalence rates.
METHODS: Six health science databases were searched from inception up to 21st January 2020. Quantitative studies investigating restraint use in residential aged care facilities that reported data from year 2000 onwards were included. Meta-analyses of binomial data using a random effect model were performed to pool proportions of physical or chemical restraints with 95% confidence intervals. Univariable meta-regression analyses were used to assess factors that may contribute to the variability in physical and chemical restraint prevalence. Multiple meta-regression analyses were performed where possible to construct models of factors contributing to these variations.
RESULTS: Eighty-five papers were included. The pooled proportion of physical and chemical restraint use in residential aged care facilities were 33% and 32% respectively. Bedrails (44%) and benzodiazepines (42%) were the most prevalent forms of physical and chemical restraint respectively. Studies from North America (lower prevalence) [coefficient (95% CI): -0.15 (-0.27, -0.03)], measurement approaches using direct observation (higher prevalence) [0.17 (0.02, 0.33)] and a combination of multiple measurement approaches (higher prevalence) [0.17 (0.05, 0.29)] explained 25.5% of variability in the prevalence of physical restraint. Multiple meta-regression analyses were not performed to identify factors that may explain the observed variability in chemical restraint prevalence due to the small number of studies with data available.
CONCLUSION: Variability in prevalence of physical restraint could be explained partly by different measurement approaches and geographical regions. Valid and reliable measurement approaches across different regions is required to understand cultural differences due to geographical region effects on the prevalence of physical restraint use.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Aged care; Chemical restraint; Measurement; Physical restraint; Prevalence; Regions; Resident; Residential facilities; Variability

Year:  2020        PMID: 33601305     DOI: 10.1016/j.ijnurstu.2020.103856

Source DB:  PubMed          Journal:  Int J Nurs Stud        ISSN: 0020-7489            Impact factor:   5.837


  4 in total

Review 1.  Variation of the Occurrence of Physical Restraint Use in the Long-Term Care: A Scoping Review.

Authors:  Elisa Ambrosi; Martina Debiasi; Jessica Longhini; Lorenzo Giori; Luisa Saiani; Elisabetta Mezzalira; Federica Canzan
Journal:  Int J Environ Res Public Health       Date:  2021-11-13       Impact factor: 3.390

2.  Incidence and type of restrictive practice use in nursing homes in Ireland.

Authors:  Paul Dunbar; Martin McMahon; Ciara Durkan; Kieran A Walsh; Laura M Keyes
Journal:  BMC Geriatr       Date:  2022-10-15       Impact factor: 4.070

3.  Association of surveillance technology and staff opinions with physical restraint use in nursing homes: Cross-sectional study.

Authors:  Lauriane Favez; Michael Simon; Michel H C Bleijlevens; Christine Serdaly; Franziska Zúñiga
Journal:  J Am Geriatr Soc       Date:  2022-04-18       Impact factor: 7.538

Review 4.  Definition and Measurement of Physical and Chemical Restraint in Long-Term Care: A Systematic Review.

Authors:  Lauren M Robins; Den-Ching A Lee; J Simon Bell; Velandai Srikanth; Ralph Möhler; Keith D Hill; Terry P Haines
Journal:  Int J Environ Res Public Health       Date:  2021-03-31       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.